key: cord-0939050-5umuo98r authors: Quino, Willi; Flores-León, Diana; Caro-Castro, Junior; Hurtado, Carmen V.; Silva, Iris; Gavilan, Ronnie G. title: Evaluation of reverse transcription-loop-mediated isothermal amplification for rapid detection of SARS-CoV-2 date: 2021-12-20 journal: Sci Rep DOI: 10.1038/s41598-021-03623-y sha: b5f0734502ae4b93a0bfd3fc9b11fa653da5ba36 doc_id: 939050 cord_uid: 5umuo98r The main strategy for response and control of COVID-19 demands the use of rapid, accurate diagnostic tests aimed at the first point of health care. During the emergency, an increase in asymptomatic and symptomatic cases results in a great demand for molecular tests, which is promoting the development and application of rapid diagnostic technologies. In this study, we describe the development and evaluation of RT-LAMP to detect SARS-CoV-2 based on three genes (ORF1ab, M and N genes) in monoplex and triplex format. RT-LAMP assays were compared with the gold standard method RT-qPCR. The triplex format (RdRp, M and N genes) allowed obtaining comparable results with de RT-qPCR (RdRp and E genes), presented a sensitivity of 98.9% and a specificity of 97.9%, opening the opportunity to apply this method to detect SARS-CoV-2 at primary health-care centers. RT-LAMP in RNA samples from patients with clinically suspected COVID-19. Five RT-LAMP assays were performed with each sample from the patients considered in this study, using four sets of oligonucleotides that amplify a fragment of nsp3 (non-structural protein 3-ORF1a), RdRp (RNA dependent RNA polymerase-ORF1b), M, N genes, and in the triplex format (RdRp, M and N mix). RT-LAMP assays were developed with the WarmStart Colorimetric LAMP 2X Master Mix -M1800 (DNA and RNA) (New England Biolabs, USA) 15 , using a mixture of RT-LAMP oligonucleotides at a final concentration of 1.6 µM FIP and (BIP); 0.2 µMof F3 and B3 primers; 0.4 μM of LF and LB. A reaction mixes with a total volume of 25 μL was prepared: containing 12.5 μl of WarmStart Colorimetric LAMP 2X Master Mix, 2.5 μl of LAMP primer mix, 5 μl of RNase-free molecular grade water (Sigma) and 5 μl of RNA. Positive and negative controls were established according to the manufacturer's recommendations. The reaction was established at 65 °C for 45 min in a Thermo Block (Thermo Scientific Inc, USA). The same procedure was developed with each LAMP sets. of the RT-LAMP to detect SARS-CoV-2 virus was carried out in triplicate using the positive control 2019-nCoV_RdRp (ORF1ab) (Integrated DNA Technologies), which contains the envelope gene and a portion of the RNA-dependent RNA polymerase (RdRp) of 2019-nCoV, which has been synthesized at a concentration of 200,000 copies/µL. The predetermined copy numbers of the biochemically synthesized RNA were serially diluted ten-fold from 10 6 copies to 10 -1 copies of the target gene per reaction. RT-qPCR to detect the RdRp gene was performed using the same dilutions of the positive control. Primer evaluation-RT-LAMP. The oligonucleotides designed in this study were evaluated with the free NCBI Primer-BLAST tool. In this analysis, a set of oligonucleotides that align in the Orf1a region was also included to detect a fragment of the nps3 gene developed by Lamb et al. 16 (Table 1) Limit of detection of 2019-nCoV_RdRp positive control RT-LAMP. The limit of detection of RT-qPCR and RT-LAMP assays for the detection of the RdRp gene were compared. For the RT-qPCR, the standard curve was linear and a correlation coefficient (R = 0.99325), a slope of − 3.199 and an efficiency of 1.05 were obtained. The LoD of the RT-qPCR was one logarithmic unit higher (1000 copies/reaction) compared to the RT-LAMP (Table 2) . Positive RT-LAMP reactions were seen visually as yellow, while negative reactions remained pink viewed with the naked eye ( Fig. 2A) . The limit of detection was confirmed by a gel electrophoresis of the RT-LAMP products (Fig. 2B ). The concentration of the evaluated sample was 48.17 ng/µL. Based on the serial dilutions from 10 0 -10 -5 , the limit of detection for the RdRp, N, M, the triplex format (RdRp, M, N genes) and nsp3 genes was up to 10 -5 dilution (Fig. 3) . TGT TGT AGC TTG TCA CAC CGT TCC ACA CAT GAC CAT TTC ACT RdRp_LoopF TAA GCA TGT TAG GCA TGG CT RdRp_LoopB AGC TAA TGA GTG TGC TCA (RdRp, M, N, nsp3) www.nature.com/scientificreports/ analysis with the RdRp gene presented a sensitivity of 98.8% and a specificity of 98.8%,the comparison with the N gene presented a sensitivity of 95.3% and a specificity of 98.8%; the comparison with the M gene obtained a sensitivity of 90.6% and a specificity of 99.6%; and the comparison with the nsp3 gene presented a sensitivity of 88.2% and a specificity of 98.4% (Fig. 4A) . The RT-qPCR based on the E gene detected a similar number of positives (n = 83) and negatives (n = 246). In the evaluation of the RT-qPCR of the E gene, in comparison with the four genes evaluated of the RT-LAMP and a mix of genes, it was determined that the amplification of the triplex format (RdRp, M, N, nsp3) presented a sensitivity of 96.4% and a specificity of 95.5%, while the comparative analysis with the RdRp gene obtained a sensitivity of 95.2% and a specificity 96.7%; the evaluation with the N gene presented a sensitivity of 94% and a specificity of 97.6%; while with the M gene obtained a sensitivity of 88% and a specificity of 98%; and the comparative analysis with the nsp3 gene presented a sensitivity of 85.5% and a specificity of 96.7% (Fig. 4B) . In the comparative evaluation of triplex RT-LAMP (RdRp, M and N genes) with RT-qPCR based on the amplification of RdRp, N and GAPH genes, no false negatives were observed, reaching a specificity of 100% and a sensitivity of 91.9%, being the positive predictive value of 100% and negative predictive value of 96.6% (Fig. 4B) . In this comparative evaluation, the RT-qPCR directed to the RdRp and E genes for the identification of the presence of SARS-CoV2 virus RNA, the positive result was considered only if a Ct value ≤ 40 was detected by the RT-qPCR (RdRp and E) . From the concordance analysis of RT-qPCR results compared with all the genes of RT-LAMP, it is evidenced that there is a high concordance of 0.9685 between the RT-qPCR (RdRp) and the RT-LAMP (RdRp) ( Table 3) Since the beginning of the pandemic caused by the SARS-CoV-2 virus 17 , it has been observed that there is a gap in the availability of molecular tests for the detection of SARS-CoV-2 based on real-time RT-qPCR. Timely and accurate laboratory diagnosis of suspected COVID-19 patients is critical during the COVID-19 pandemic response 18 . This study demonstrates the potential use of a rapid RT-LAMP-based method for the detection of SARS-CoV-2 with high specificity and sensitivity. RT-LAMP has been selected because it provides a rapid and reliable diagnostic alternative for the detection of infectious agents in settings with limited resources such as dengue virus, Zika, chikungunya, influenza, yellow fever among other viruses [19] [20] [21] . Although ORF1ab is the confirmatory target gene with the highest specificity, it is considered less sensitive than other clinicallyapplicable targets [22] [23] [24] . Although diagnostic assays can be designed in the most conserved region of the viral genome, most of the RT-qPCR and RT-LAMP routinely applied target the ORF1ab, RdRp, S, E and N genes due to their high level of transcription and abundance of expression compared to other SARS-CoV-2 genes 25 , so the design of our oligonucleotides were directed towards these targets. The high sensitivity and specificity of RT-LAMP obtained in this study is noteworthy, particularly since it is based on the comparison with the reference method RT-qPCR (RdRp and E) and the amplification of multiple genes of RT-LAMP. These findings have great importance, both clinically and epidemiologically due to the high cases of symptomatic and asymptomatic patients of COVID-19 26, 27 , which explain the necessity of the development and application of a portable rapid diagnostic test with good sensitivity and specificity to identify these cases. In this RT-LAMP optimization assays, the LoD was one logarithmic unit lower (1000 copies/reaction) than the RT-qPCR, when using the positive control 2019-nCoV_RdRp (ORF1ab) ( Table 2) . This result showed RT-LAMP assays are more sensitive than RT-qPCR. Several studies using the protocol developed by Corman et al. 14 reported RT-qPCR assays could not detect most samples with Ct > 30. This group of samples is usually subject to wrong diagnostic treatment or to no treatment at all, spreading the disease to others 28 . Previous studies indicate that Ct > 30 values showed patients without infective capacity, but there is not a real consensus 29 . Additionally, RT-LAMP assays previously reported reaffirm being more sensitive than RT-qPCR, detecting a smaller number of copies, including samples with Ct values between 31-35. For example, Bharda et al. reported that the use of a set of six primers for RT-LAMP can detect 100 to 1000 copies of SARS-CoV-2 genomic RNA 30 . Similarly, Chan et al. 31 described a RT-LAMP with a LoD of 11.2 RNA copies per reaction using in vitro RNA transcripts, while Yan et al. 32 adapted the ORF1ab gene to develop a RT-LAMP with a limit of detection of 20 copies per reaction. Most of these diagnostic tests have a high level of sensitivity, specificity, and repeatability; however, these mainly lack clinical validation 33 . In this study, we performing a RT-LAMP using five sets of oligonucleotides, the triplex format (RdRp, M, N) was the one which presented a sensitivity of 98.9% and a specificity of 97.9% when was compared to the RT-qPCR (RdRp gene and E gene), since the ORF1ab gene is very specific and the N gene is very sensitive in addition to the M gene, data very similar to the reported by Yang et al. 34 with a sensitivity of 99%. Likewise, the highly conserved RdRp gene presented a sensitivity and a specificity of 98.8%, very similar to those reported by Kitagawa et al. 35 , who obtained a sensitivity and a specificity of 100% and 97% respectively, as well as the sensitivity and specificity for the N and M genes: 95.3% and 98.8%; 90.6% and 99.6% respectively, data very similar to that reported by Jiang et al. 36 with a sensitivity and specificity of 91.4% and 99.5%, respectively, while the sensitivity and specificity for the nsp3 gene was 88.2% and 98.4% respectively, data very similar to the reported by Hu et al. 37 38 and Dao Thi et al. 39 reported sensitivities of 97.6%, and 97.5% respectively, which were comparable to results of this study. However, the study of Escalante-Maldonado et al. 40 obtained lower sensitivity (87.4%) than this study. In contrast, RT-LAMP triplex assays were reported based on different sets of primers, having advantages and disadvantages when they are compared to this study. Yamazaki et al. 41 , using primers for ORF1ab, S and ORF7a regions, obtaining a sensitivity of 82.6% and specificity of 100% and showing the poorest sensibility compared to nasal-pharyngeal samples. Another, study reported by Sherrill-Mix et al. 42 using primers E1 (E protein), As1e (ORF1a), and Penn (ORF1ab), getting a LoD greater than 100 copies/ reaction that was comparable to this study results. Juscamayta-Lopez et al. 43 included the RdRp, M and N genes for their triplex RT-LAMP with sensitivity and specificity values of 100.0% and 98.6% that were comparable to this study. However, the method needs to use a turbidimeter equipment to measure the color change during the assay which is difficult to apply in low-resource settings. An important limitation for RT-LAMP assay is the RNA extraction and purification, which is essential during the use of nasal-pharyngeal or saliva samples without RNA purification. Some studies overcome these difficulties by applying different strategies such as Wei et al. 44 that designed a method without the need for prior RNA extraction, processing samples inside transport media in 30 min and obtaining a high sensitivity. However, the sensitivity is strongly affected by processing samples after 30 min. In this study, we performed RT-LAMP assays including samples stored to − 80 °C from a few days to several months, and the sensitivity was not affected. In conclusion, the RT-LAMP using the triplex format (RdRp, M and N genes) was the one which obtained best numbers of sensitivity (98.9%) and specificity (97.7%), obtaining comparable results with RT-qPCR to detect SARS-CoV-2 RNA virus in nasal and pharyngeal swabs, opening the opportunity to perform this method from patients with suspected COVID-19 at primary health-care centers. Clinical features of patients infected with 2019 novel coronavirus in Wuhan First case of 2019 novel coronavirus in the United States news/ item/ 30-01-2020-state ment-on-thesecond-meeti ng-of-the-inter natio nal-health-regul ations-(2005)-emerg ency-commi ttee-regar ding-the-outbr eak-of-novel-coron avirus-(2019-ncov) Johns Hopkins Coronavirus Resource Center. COVID-19 Map Covid 19 en el Perú A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster Evidence for SARS-CoV-2 infection of animal hosts A pneumonia outbreak associated with a new coronavirus of probable bat origin Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan The architecture of SARS-CoV-2 transcriptome An emerging coronavirus causing pneumonia outbreak in Wuhan, China: Calling for developing therapeutic and prophylactic strategies Loop-mediated isothermal amplification of DNA Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-qPCR WarmStart Colorimetric LAMP 2X Master Mix (DNA andRNA) | NEB.https:// inter natio nal. neb. com/ produ cts/ m1800-warms tart-color imetr ic-lamp-2x-master-mix-dna-rna Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification World Health Organization. Coronavirus disease (COVID-19) pandemic The SARS-CoV-2 outbreak: What we know Rapid identification of chikungunya and dengue virus by a real-time reverse transcription-loop-mediated isothermal amplification method Rapid and sensitive detection of novel avian-origin influenza A (H7N9) virus by reverse transcription loop-mediated isothermal amplification combined with a lateral-flow device A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus Genomic characterization of a novel SARS-CoV-2 Coronavirus genome replication Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-qPCR detection kits and strategy to reduce false negative Rapid detection of SARS-CoV-2 using reverse transcription RT-LAMP method Novel coronavirus infection in hospitalized infants under 1 year of age in China Relationship between circulating microRNA-30c with total-and LDLcholesterol, their circulatory transportation and effect of statins Colorimetric RT-LAMP SARS-CoV-2 diagnostic sensitivity relies on color interpretation and viral load Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients High-surety isothermal amplification and detection of SARS-CoV-2, including with crude enzymes Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/hel realtime reverse transcription-PCR assay validated in vitro and with clinical specimens Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay Viral load of SARS-CoV-2 in clinical samples Rapid and accurate detection of three genes in SARS-CoV-2 using RT-LAMP method Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification Development and validation of a rapid, single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19 Development and clinical application of a rapid and sensitive loop-mediated isothermal amplification test for SARS-CoV-2 infection Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) Diagnostic platform A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples Estandarización y validación de una prueba molecular RT-LAMP in house para el diagnóstico de SARS-CoV-2 Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detection Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons A Multiplex and colorimetric reverse transcription loop-mediated isothermal amplification assay for sensitive and rapid detection of novel SARS-CoV-2. Front Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction We thank the members of the National Reference Laboratory of Enteropathogens (INS-Peru) for their technical assistance. This work was supported by the project "Platform for the genotyping of SARS-COV-2 virus", approved by Institutional Review Boards of Instituto Nacional de Salud of Peru according to D.R. N°191-2020-OGITT/INS. W.Q. and R.G. participated in the conception, hypothesis delineation and study design. C.H. and I.S. conducted PCR assays. D.F. and J.C. participated in the analysis, interpretation of data and writing of the article. W.Q. and R.G. participated in the critical review of the article. The authors declare no competing interests. The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-03623-y.Correspondence and requests for materials should be addressed to R.G.G.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.